%, compared with the same period of the last year. As a result of operating profit that significant growth and finance costs are very low level because of the stable financial position. DOD BIOTECH PUBLIC

&A”) closed at 83.78mb (Q3 2018: 58.51mb), increased by 25.27mb or 43.2% . SG&A consists of mainly indirect staff costs, office rental and depreciation & amortization. The increase in SG&A is mainly

-664 -18% -549 -16% 17% -1,599 -21% -2,072 -17% 30% Finance costs -238 -7% -239 -7% 0% -662 -9% -816 -7% 23% Net gains on exchange rate -65 -2% 79 2% 223% 152 2% 369 3% 143% Share of loss from investment

gross profit margin. Operating Results and Capabilities to Make Profit Performance from revenues, costs and expenses which has significant impact in Q3-2019 can be shown in the following table: -2

Services 2,060,114 2,473,795 -17% 1,640,996 1,631,566 1% Costs of Sales and Services (1,431,003) (2,029,194) -29% (1,057,056) (1,071,607) -1% Gross profit 629,111 444,601 42% 583,940 559,959 4% Interest

equity shares issued for payment of assets Equity shares issued for payment of assets x 100 Issued and paid-up shares of the Company This cannot be calculated. Upon combination of the transactions on

to reduce costs in terms of wages, salaries and some unnecessary expenses. Apr May Jun Jul Aug Sep Close 1 Apr. - Veranda Chiang Mai - So Bangkok - Rocky Boutique Close 4 Apr - Veranda resort Hua-Hin

. Operating Results and Capabilities to Make Profit Performance from revenues, costs and expenses which has significant impact in Q1-2020 can be shown in the following table: Balance by Quarter Change Q1–20 Q4

income 348 31% 65 2% -81% Selling expense -138 -12% -306 -10% 121% Administrative expense -286 -25% -437 -15% 53% Finance costs -136 -12% -207 -7% 52% Net gains on exchange rate 0 0% 91 3% n/a Share of

% Administrative expense -281 -29% -573 -24% 104% Finance costs -116 -12% -165 -7% 43% Net gains on exchange rate -349 -37% 171 7% 149% Share of loss from investment in joint ventures -33 -3% 33 1% 200% EBT 294 31